Addressing the Controversy of Rate Versus Rhythm Control in Atrial Fibrillation

References

• . Lloyd-Jones DM, Wang TJ, Leip EP, . Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110(9):1042–1046
   PubMed Web of Science ®Google Scholar
• . Miyasaka Y, Barnes ME, Gersh BJ, . Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114(2):119–125
   PubMed Web of Science ®Google Scholar
• . Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22(8):983–988
   PubMed Web of Science ®Google Scholar
• . Lin HJ, Wolf PA, Kelly-Hayes M, . Stroke severity in atrial fibrillation: The Framingham Study. Stroke. 1996;27(10):1760–1764
   PubMed Web of Science ®Google Scholar
• . Lim HS, Willoughby SR, Schultz C, . Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm. J Am Coll Cardiol. 2013;61(8):852–860
   PubMed Web of Science ®Google Scholar
• . Grogan M, Smith HC, Gersh BJ, Wood DL. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol. 1992;69(19):1570–1573
   PubMed Web of Science ®Google Scholar
• . Umana E, Solares CA Alpert MA. Tachycardia-induced cardiomyopathy. Am J Med. 2003;114(1):51–55
   PubMedGoogle Scholar
• . Dries D, Exner D, Gersh B, Domanski M, Waclawiw M, Stevenson L. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. J Am Coll Cardiol. 1998;32(3):695–703
   PubMed Web of Science ®Google Scholar
• . Middlekauff HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation. 1991;84(1):40–48
   PubMed Web of Science ®Google Scholar
• . Roy D, Talajic M, Dubuc M, . Atrial fibrillation and congestive heart failure. Curr Opin Cardiol. 2009;24(1):29–34
   PubMedGoogle Scholar
• . Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation. 1998;98(10):946–952
   PubMed Web of Science ®Google Scholar
• . Miyasaka Y, Barnes ME, Bailey KR, . Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study. J Am Coll Cardiol. 2007;49(9):986–992
   PubMed Web of Science ®Google Scholar
• . Friberg L, Hammar N, Pettersson H, Rosenqvist M. Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF). Eur Heart J. 2007;28(19):2346–2353
   PubMed Web of Science ®Google Scholar
• . Singh SN, Tang XC, Singh BN, . Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a veterans affairs cooperative studies program substudy J Am Coll Cardiol. 2006;48(4):721–730
   PubMedGoogle Scholar
• . Marzona I, O'Donnell M, Teo K, . Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTAR-GET and TRANSCEND studies. CMAJ. 2012;184(6):E329–E336
   PubMed Web of Science ®Google Scholar
• . Jared Bunch T, May HT, Bair TL, . Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 Score. Heart Rhythm. 2013: Epub ahead of print
   Google Scholar
• . Chinirz JS, Halperin JL, Reddy VY, Fuster V. Rate or rhythm control for atrial fibrillation: update and controversies. Am J Med. 2012;125(11):1049–1056
   PubMedGoogle Scholar
• . Hohnloser SH, Kuck K-H, Lilienthal J. Rhythm or rate control in atrial fibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet. 2000;356(9244):1789–1794
   PubMed Web of Science ®Google Scholar
• . Grönefeld GC, Lilienthal J, Kuck K-H, Hohnloser SH. Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation Results from a prospective randomized study. Eur Heart J. 2003;24(15):1430–1436
   PubMedGoogle Scholar
• . Carlsson Jö, Miketic S, Windeler Jü, . Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation. J Am Coll Cardiol. 2003;41(10):1690–1696
   PubMed Web of Science ®Google Scholar
• . Van Gelder IC, Hagens VE, Bosker HA, . A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. New Engl J Med. 2002;347(23):1834–1840
   PubMed Web of Science ®Google Scholar
• . Opolski G, Torbicki A, Kosior DA, . Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish how to treat chronic atrial fibrillation (HOT CAFE) study. Chest. 2004;126(2):476–486
   PubMed Web of Science ®Google Scholar
• . Wyse D, Waldo A, DiMarco J, . Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347(23):1825–1833
   PubMed Web of Science ®Google Scholar
• . Roy D, Talajic M, Nattel S, . Rhythm control versus rate Control for atrial fibrillation and heart failure. New Engl J Med. 2008;358(25):2667–2677
   PubMed Web of Science ®Google Scholar
• . Bardy G, Lee K, Mark D, Poole J, Fishbein D, Singh S. Sudden Cardiac Death-Heart Failure Trial (SCD-HeFT). Arrhythmia treatment and therapy: evaluation of clinical trial evidence New York: Marcel Dekker 2000:323–42
   Google Scholar
• . Shelton RJ, Clark AL, Goode K, . A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure:(CAFE-II Study). Heart. 2009;95(11):924–930
   PubMed Web of Science ®Google Scholar
• . Jancin B. Rhythm control better for paroxysmal atrial fib. Cardiology News. 2007. http://www.ecardiologynews.com/index.php?id=8628&cHash=071010&tx_ttnews[tt_news]=85836. Accessed May 22, 2013
   Google Scholar
• . Ogawa S, Yamashita T, Yamazaki T, . Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study. Circ J. 2009;73:242–248
   PubMed Web of Science ®Google Scholar
• . Ionescu-Ittu R, Abrahamowicz M, Jackevicius CA . Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality inpatients with atrial fibrillation. Arch Intern Med. 2012;172(13):997–1004
   PubMedGoogle Scholar
• . Corley S, Epstein A, DiMarco J, ; AFFIRM Investigators. Relationships between sinus rhythm, treatment, and survival in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study. Circulation. 2004;109(12):1509–1513
   PubMed Web of Science ®Google Scholar
• . Deedwania PC, Singh BN, Ellenbogen K, Fisher S, Fletcher R, Singh SN. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). Circulation. 1998;98(23):2574–2579
   PubMed Web of Science ®Google Scholar
• . Pedersen OD, Bagger H, Keller N, . Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality ON Dofetilide (DIAMOND) substudy. Circulation. 2001;104(3):292–296
   PubMed Web of Science ®Google Scholar
• . Friberg L, Hammar N, Edvardsson N, Rosenqvist M. The prognosis of patients with atrial fibrillation is improved when sinus rhythm is restored: report from the Stockholm Cohort of Atrial Fibrillation (SCAF). Heart. 2009;95(12):1000–1005
   PubMedGoogle Scholar
• . Camm AJ, Breithardt G, Crijns H, . Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation). J Am Coll Cardiol. 2011;58(5):493–501
   PubMedGoogle Scholar
• . Burkhardt JD, Di Biase L, Natale A. Long-standing persistent atrial fibrillation the metastatic cancer of electrophysiology J Am Coll Cardiol. 2012;60(19):1930–1932
   PubMedGoogle Scholar
• . Camm AJ, Kirchhof P, Lip GY, . Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010;12(10):1360–1420
   PubMed Web of Science ®Google Scholar
• . Wilber D, Pappone C, Neuzil P, ; ThermoCool AF Trial Investigators. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA. 2010;303(4):333–340
   PubMed Web of Science ®Google Scholar
• . Hunter RJ, McCready J, Diab I, . Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death. Heart. 2012;98(1):48–53
   PubMed Web of Science ®Google Scholar
• . Calkins H, Reynolds MR, Spector P, . Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol. 2009;2(4):349–361
   PubMed Web of Science ®Google Scholar
• . Jones DG, Haldar SK, Hussain W, . Arandomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. J Am Coll Cardiol. 2013;61(18):1894–1903
   PubMed Web of Science ®Google Scholar
• . Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet. 2008;372(9641):817–821
   PubMed Web of Science ®Google Scholar
• . Swedberg K, Komajda M, Böhm M, ; SHIFT Investigators. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet. 2010;376(9744):875–85
   PubMed Web of Science ®Google Scholar
• . Van Gelder IC, Groenveld HF, Crijns HJGM, ; RACE II Investigators. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med. 2010;362(15):1363–1373
   PubMed Web of Science ®Google Scholar
• . Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res. 2002;54(2):230–246
   PubMed Web of Science ®Google Scholar
• . Dittrich HC, Erickson JS, Schneiderman T, Blacky AR, Savides T, Nicod PH. Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. Am J Cardiol. 1989;63(3):193–197
   PubMed Web of Science ®Google Scholar
• . ClinicalTrials.gov. Early Treatment of Atrial Fibrillation for Stroke Prevention Trial (EAST). 2013. http://clinicaltrials.gov/ct2/show/NCT01288352?term=EAST&rank=1. Accessed August 4, 2013
   Google Scholar
• . ClinicalTrials.gov. Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial (CABANA). 2013. http://clinicaltrials.gov/ct2/show/NCT00911508. Accessed August 4, 2013
   Google Scholar
• . Camm A Savelieva I. Atrial fibrillation: the rate versus rhythm management controversy. JR Coll Physicians Edinb. 2012;42(18):23–34
   PubMedGoogle Scholar
• . Hagens VE, Ranchor AV, Van Sonderen E, . Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study. J Am Coll Cardiol. 2004;43(2):241–247
   PubMed Web of Science ®Google Scholar
• . Wyse D, Waldo A, DiMarco J, . A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347(23):1825–1833
   PubMed Web of Science ®Google Scholar